Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Inecalcitol (TX 522) 是一种独特的维生素 D3 类似物,可诱导细胞凋亡,有抗癌活性。它是一种具有口服活性维生素 D 受体激动剂,Kd 为 0.53 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 5,390 | 现货 | ||
5 mg | ¥ 11,200 | 现货 | ||
10 mg | ¥ 14,900 | 现货 | ||
25 mg | ¥ 22,500 | 现货 | ||
50 mg | ¥ 29,700 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 14,800 | 现货 |
产品描述 | Inecalcitol (TX 522) is the growth inhibitor of human breast cancer cells. Inecalcitol is a unique vitamin D3 analog with Kd of 0.53 nM. |
靶点活性 | Vitamin D3:0.53 nM(Kd) |
体外活性 | A xenograft model of LNCaP cells was developed in immunodeficient mice treated with inecalcitol. The tumors of the diluent-treated control mice increased in size but those in the inecalcitol treatment group did not grow[1]. |
体内活性 | Inecalcitol maximal tolerated dose (MTD) by intraperitoneal (i.p.) administration was 30 μg/mouse (1,300 μg/kg) three times per week, while we previously found that the MTD of 1,25(OH)(2) D(3) is 0.0625 μg/mouse; therefore, inecalcitol is 480 times less hypercalcemic than 1,25OH2 D3[1]. Inecalcitol inhibits androgen-responsive prostate cancer growth in vivo. |
别名 | TX 522, TX-522, TX522, 伊奈骨化醇 |
分子量 | 400.59 |
分子式 | C26H40O3 |
CAS No. | 163217-09-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/ml (137.3 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.4963 mL | 12.4816 mL | 24.9632 mL | 62.4079 mL |
5 mM | 0.4993 mL | 2.4963 mL | 4.9926 mL | 12.4816 mL | |
10 mM | 0.2496 mL | 1.2482 mL | 2.4963 mL | 6.2408 mL | |
20 mM | 0.1248 mL | 0.6241 mL | 1.2482 mL | 3.1204 mL | |
50 mM | 0.0499 mL | 0.2496 mL | 0.4993 mL | 1.2482 mL | |
100 mM | 0.025 mL | 0.1248 mL | 0.2496 mL | 0.6241 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Inecalcitol 163217-09-2 Apoptosis anticancer antiproliferative TX 522 Vitamin D ETV1 Pim-1 Vitamin D receptor VDR VD/VDR TX-522 Inhibitor inhibit TX522 伊奈骨化醇 inhibitor